Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
November 20, 2018
Patent Application Number
15847697
Date Filed
December 19, 2017
Patent Citations Received
US Patent 12077554 CDK9 inhibitors and polymorphs thereof for use as agents for treatment of cancer
US Patent 11034710 CDK9 inhibitors and polymorphs thereof for use as agents for treatment of cancer
US Patent 11530231 CDK9 inhibitors and polymorphs thereof for use as agents for treatment of cancer
...
Patent Primary Examiner
Patent abstract
The present disclosure is generally directed to profiling peptides, compositions, and kits, as well as methods of use thereof. The profiling peptides comprise an Mcl-1 binding domain, and optionally a cellular uptake moiety. The methods of using such profiling peptides include predicting sensitivity of a cancer, selecting a treatment, treating a cancer, producing a sensitivity profile, and the like.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.